Granules India has informed that Granules Pharmaceuticals, Inc., a Wholly Owned foreign subsidiary of the Company, has incorporated a Wholly Owned Subsidiary (WOS), namely ‘Granules Pharmaceuticals Canada, Inc.’ in Canada on November 26, 2025. In terms of the Listing Regulations read with the SEBI Circular No SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023 on Disclosure of material events/information, we are furnishing herewith the details in the enclosed Annexure.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: